BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Salazar N, Castellan M, Shirodkar SS, Lokeshwar BL. Chemokines and chemokine receptors as promoters of prostate cancer growth and progression. Crit Rev Eukaryot Gene Expr 2013;23:77-91. [PMID: 23557339 DOI: 10.1615/critreveukaryotgeneexpr.2013006905] [Cited by in Crossref: 46] [Cited by in F6Publishing: 30] [Article Influence: 5.1] [Reference Citation Analysis]
Number Citing Articles
1 Zhu X, Liu L, Wang Y, Cong J, Lin Z, Wang Y, Liu Q, Wang L, Yang B, Li T. lncRNA MIAT/HMGB1 Axis Is Involved in Cisplatin Resistance via Regulating IL6-Mediated Activation of the JAK2/STAT3 Pathway in Nasopharyngeal Carcinoma. Front Oncol 2021;11:651693. [PMID: 34094941 DOI: 10.3389/fonc.2021.651693] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Yang S, Wang H, Qin C, Sun H, Han Y. Up-regulation of CXCL8 expression is associated with a poor prognosis and enhances tumor cell malignant behaviors in liver cancer. Biosci Rep 2020;40:BSR20201169. [PMID: 32766720 DOI: 10.1042/BSR20201169] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
3 Hoy JJ, Kallifatidis G, Smith DK, Lokeshwar BL. Inhibition of androgen receptor promotes CXC-chemokine receptor 7-mediated prostate cancer cell survival. Sci Rep 2017;7:3058. [PMID: 28596572 DOI: 10.1038/s41598-017-02918-3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
4 Tsai CH, Tzeng SF, Hsieh SC, Yang YC, Hsiao YW, Tsai MH, Hsiao PW. A standardized herbal extract mitigates tumor inflammation and augments chemotherapy effect of docetaxel in prostate cancer. Sci Rep 2017;7:15624. [PMID: 29142311 DOI: 10.1038/s41598-017-15934-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
5 Chen K, Wu K, Jiao X, Wang L, Ju X, Wang M, Di Sante G, Xu S, Wang Q, Li K, Sun X, Xu C, Li Z, Casimiro MC, Ertel A, Addya S, McCue PA, Lisanti MP, Wang C, Davis RJ, Mardon G, Pestell RG. The endogenous cell-fate factor dachshund restrains prostate epithelial cell migration via repression of cytokine secretion via a cxcl signaling module. Cancer Res 2015;75:1992-2004. [PMID: 25769723 DOI: 10.1158/0008-5472.CAN-14-0611] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 2.6] [Reference Citation Analysis]
6 Wang LP, Cao J, Zhang J, Wang BY, Hu XC, Shao ZM, Wang ZH, Ou ZL. The human chemokine receptor CCRL2 suppresses chemotaxis and invasion by blocking CCL2-induced phosphorylation of p38 MAPK in human breast cancer cells. Med Oncol 2015;32:254. [PMID: 26487662 DOI: 10.1007/s12032-015-0696-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
7 Huang R, Guo L, Gao M, Li J, Xiang S. Research Trends and Regulation of CCL5 in Prostate Cancer. Onco Targets Ther 2021;14:1417-27. [PMID: 33664576 DOI: 10.2147/OTT.S279189] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
8 Zhu L, Wang C, Jiang H, Zhang L, Mao L, Zhang Y, Qi S, Liu X. Quizalofop-P-ethyl induced developmental toxicity and cardiotoxicity in early life stage of zebrafish (Danio rerio). Ecotoxicology and Environmental Safety 2022;238:113596. [DOI: 10.1016/j.ecoenv.2022.113596] [Reference Citation Analysis]
9 Ganguly SS, Li X, Miranti CK. The host microenvironment influences prostate cancer invasion, systemic spread, bone colonization, and osteoblastic metastasis. Front Oncol 2014;4:364. [PMID: 25566502 DOI: 10.3389/fonc.2014.00364] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 3.9] [Reference Citation Analysis]
10 Kallifatidis G, Munoz D, Singh RK, Salazar N, Hoy JJ, Lokeshwar BL. β-Arrestin-2 Counters CXCR7-Mediated EGFR Transactivation and Proliferation. Mol Cancer Res 2016;14:493-503. [PMID: 26921391 DOI: 10.1158/1541-7786.MCR-15-0498] [Cited by in Crossref: 23] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
11 Karan D, Dubey S. From Inflammation to Prostate Cancer: The Role of Inflammasomes. Adv Urol 2016;2016:3140372. [PMID: 27429614 DOI: 10.1155/2016/3140372] [Cited by in F6Publishing: 33] [Reference Citation Analysis]
12 Lindholm PF, Sivapurapu N, Jovanovic B, Kajdacsy-Balla A. Monocyte-Induced Prostate Cancer Cell Invasion is Mediated by Chemokine ligand 2 and Nuclear Factor-κB Activity. J Clin Cell Immunol 2015;6:308. [PMID: 26317041 DOI: 10.4172/2155-9899.1000308] [Cited by in Crossref: 3] [Cited by in F6Publishing: 12] [Article Influence: 0.4] [Reference Citation Analysis]
13 Yildirim G, Attar R, Gulec-Yilmaz S, Duman S, Isbir T. Association of CCR2 (+190 G/A) Gene Variants and Ovarian Cancer Severity. Genet Test Mol Biomarkers 2017;21:512-5. [PMID: 28650671 DOI: 10.1089/gtmb.2017.0008] [Reference Citation Analysis]
14 Mir H, Singh R, Kloecker GH, Lillard JW Jr, Singh S. CXCR6 expression in non-small cell lung carcinoma supports metastatic process via modulating metalloproteinases. Oncotarget 2015;6:9985-98. [PMID: 25888629 DOI: 10.18632/oncotarget.3194] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 3.7] [Reference Citation Analysis]
15 Mo M, Zhou M, Wang L, Qi L, Zhou K, Liu LF, Chen Z, Zu XB. CCL21/CCR7 enhances the proliferation, migration, and invasion of human bladder cancer T24 cells. PLoS One 2015;10:e0119506. [PMID: 25798926 DOI: 10.1371/journal.pone.0119506] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 4.3] [Reference Citation Analysis]
16 Jin YB, Zhang GY, Lin KR, Chen XP, Cui JH, Wang YJ, Luo W. Changes of plasma cytokines and chemokines expression level in nasopharyngeal carcinoma patients after treatment with definitive intensity-modulated radiotherapy (IMRT). PLoS One 2017;12:e0172264. [PMID: 28207826 DOI: 10.1371/journal.pone.0172264] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
17 Zhao Y. The mysterious relation between inflammation and prostate cancer. Infection International 2017;6:8-12. [DOI: 10.1515/ii-2017-0154] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
18 Mughees M, Kaushal JB, Sharma G, Wajid S, Batra SK, Siddiqui JA. Chemokines and Cytokines: Axis and Allies in Prostate Cancer Pathogenesis. Semin Cancer Biol 2022:S1044-579X(22)00041-4. [PMID: 35181473 DOI: 10.1016/j.semcancer.2022.02.017] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
19 Taverna G, Pedretti E, Di Caro G, Borroni EM, Marchesi F, Grizzi F. Inflammation and prostate cancer: friends or foe? Inflamm Res 2015;64:275-86. [PMID: 25788425 DOI: 10.1007/s00011-015-0812-2] [Cited by in Crossref: 31] [Cited by in F6Publishing: 34] [Article Influence: 4.4] [Reference Citation Analysis]
20 Ruiz-Plazas X, Rodríguez-Gallego E, Alves M, Altuna-Coy A, Lozano-Bartolomé J, Portero-Otin M, García-Fontgivell JF, Martínez-González S, Segarra J, Chacón MR. Biofluid quantification of TWEAK/Fn14 axis in combination with a selected biomarker panel improves assessment of prostate cancer aggressiveness. J Transl Med 2019;17:307. [PMID: 31500625 DOI: 10.1186/s12967-019-2053-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
21 Nagaya N, Lee GT, Horie S, Kim IY. CXC Chemokine/Receptor Axis Profile and Metastasis in Prostate Cancer. Front Mol Biosci 2020;7:579874. [PMID: 33195424 DOI: 10.3389/fmolb.2020.579874] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
22 Sciarra A, Gentilucci A, Salciccia S, Pierella F, Del Bianco F, Gentile V, Silvestri I, Cattarino S. Prognostic value of inflammation in prostate cancer progression and response to therapeutic: a critical review. J Inflamm (Lond) 2016;13:35. [PMID: 27924136 DOI: 10.1186/s12950-016-0143-2] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 4.0] [Reference Citation Analysis]
23 Dushyanthen S, Cossigny DA, Quan GM. The osteoblastic and osteoclastic interactions in spinal metastases secondary to prostate cancer. Cancer Growth Metastasis 2013;6:61-80. [PMID: 24665208 DOI: 10.4137/CGM.S12769] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
24 Wang L, Zhang C, Xu J, Wu H, Peng J, Cai S, He Y. CXCL1 gene silencing inhibits HGC803 cell migration and invasion and acts as an independent prognostic factor for poor survival in gastric cancer. Mol Med Rep 2016;14:4673-9. [PMID: 27748927 DOI: 10.3892/mmr.2016.5843] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
25 Chen G, Liang YX, Zhu JG, Fu X, Chen YF, Mo RJ, Zhou L, Fu H, Bi XC, He HC, Yang SB, Wu YD, Jiang FN, Zhong WD. CC chemokine ligand 18 correlates with malignant progression of prostate cancer. Biomed Res Int 2014;2014:230183. [PMID: 25197632 DOI: 10.1155/2014/230183] [Cited by in Crossref: 20] [Cited by in F6Publishing: 28] [Article Influence: 2.5] [Reference Citation Analysis]
26 Guérard A, Laurent V, Fromont G, Estève D, Gilhodes J, Bonnelye E, Le Gonidec S, Valet P, Malavaud B, Reina N, Attané C, Muller C. The Chemokine Receptor CCR3 Is Potentially Involved in the Homing of Prostate Cancer Cells to Bone: Implication of Bone-Marrow Adipocytes. Int J Mol Sci 2021;22:1994. [PMID: 33671469 DOI: 10.3390/ijms22041994] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Laurent V, Guérard A, Mazerolles C, Le Gonidec S, Toulet A, Nieto L, Zaidi F, Majed B, Garandeau D, Socrier Y. Periprostatic adipocytes act as a driving force for prostate cancer progression in obesity. Nat Commun. 2016;7:10230. [PMID: 26756352 DOI: 10.1038/ncomms10230] [Cited by in Crossref: 127] [Cited by in F6Publishing: 136] [Article Influence: 21.2] [Reference Citation Analysis]
28 Strömvall K, Thysell E, Halin Bergström S, Bergh A. Aggressive rat prostate tumors reprogram the benign parts of the prostate and regional lymph nodes prior to metastasis. PLoS One 2017;12:e0176679. [PMID: 28472073 DOI: 10.1371/journal.pone.0176679] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
29 Hillerdal V, Essand M. Chimeric antigen receptor-engineered T cells for the treatment of metastatic prostate cancer. BioDrugs 2015;29:75-89. [PMID: 25859858 DOI: 10.1007/s40259-015-0122-9] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 4.4] [Reference Citation Analysis]
30 Hu Y, Lu L, Xia Y, Chen X, Chang AE, Hollingsworth RE, Hurt E, Owen J, Moyer JS, Prince ME, Dai F, Bao Y, Wang Y, Whitfield J, Xia JC, Huang S, Wicha MS, Li Q. Therapeutic Efficacy of Cancer Stem Cell Vaccines in the Adjuvant Setting. Cancer Res 2016;76:4661-72. [PMID: 27325649 DOI: 10.1158/0008-5472.CAN-15-2664] [Cited by in Crossref: 30] [Cited by in F6Publishing: 20] [Article Influence: 5.0] [Reference Citation Analysis]
31 Caggia S, Chunduri H, Millena AC, Perkins JN, Venugopal SV, Vo BT, Li C, Tu Y, Khan SA. Novel role of Giα2 in cell migration: Downstream of PI3-kinase-AKT and Rac1 in prostate cancer cells. J Cell Physiol 2018;234:802-15. [PMID: 30078221 DOI: 10.1002/jcp.26894] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
32 Liu P, Liang Y, Jiang L, Wang H, Wang S, Dong J. CX3CL1/fractalkine enhances prostate cancer spinal metastasis by activating the Src/FAK pathway. Int J Oncol 2018;53:1544-56. [PMID: 30066854 DOI: 10.3892/ijo.2018.4487] [Cited by in Crossref: 7] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
33 Sun J, Feng C, Liao W, Zhang H, Tang S. Expression of CXC chemokine receptor-4 and forkhead box 3 in neuroblastoma cells and response to chemotherapy. Oncol Lett 2014;7:2083-8. [PMID: 24932293 DOI: 10.3892/ol.2014.2028] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
34 Kumar S, Singh R, Malik S, Manne U, Mishra M. Prostate cancer health disparities: An immuno-biological perspective. Cancer Lett 2018;414:153-65. [PMID: 29154974 DOI: 10.1016/j.canlet.2017.11.011] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]